Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

471
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
471
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

871
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
871

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular, metabolic, and histological subtypes of pancreatic ductal adenocarcinoma and its tumor microenvironment: Insights into tumor heterogeneity and clinical implications.

Pharmacology & therapeuticsยท2025
Same author

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.

Carcinogenesisยท2024
Same author

ADRA2A promotes the classical/progenitor subtype and reduces disease aggressiveness of pancreatic cancer.

bioRxiv : the preprint server for biologyยท2024
Same author

ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer.

International journal of cancerยท2024
Same author

LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism.

Carcinogenesisยท2024
Same author

SERPINB3-MYC axis induces the basal-like/squamous subtype and enhances disease progression in pancreatic cancer.

Cell reportsยท2023
Same journal

Deciphering the Neuroautophagic Interactome: Molecular Circuits Linking Selective Autophagy to Neuropathological Cascades in Neurological Disorders.

International journal of biological sciencesยท2026
Same journal

Targeting THOC2-Mediated mRNA Export Induces PARP Inhibitor Vulnerability in DNA Repair-Competent Hepatocellular Carcinoma.

International journal of biological sciencesยท2026
Same journal

Targeting IL-1ฮฑ Sensitizes HNSCC to PDT by Reversing Hypoxia and NF-ฮบB-Driven Oxidative Stress Resistance.

International journal of biological sciencesยท2026
Same journal

Nicotinamide riboside reduces glial inflammation and boosts mitochondrial function.

International journal of biological sciencesยท2026
Same journal

Spatial and single-cell transcriptomics reveal a HIF-1ฮฑ/NF-ฮบB-driven hypoxia-induced senescence axis in BPH epithelium.

International journal of biological sciencesยท2026
Same journal

Sleep Deprivation Promotes Colorectal Cancer in Apc<sup>Min/+</sup> Mice Associated with Modulation of Gut Microbiota and Related Metabolites.

International journal of biological sciencesยท2026
See all related articles

Related Experiment Video

Updated: Mar 24, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.6K

Pancreatic Cancer: Current Progress and Future Challenges.

S Perwez Hussain1

  • 1Head Pancreatic Cancer Unit, Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institutes, NIH, Bethesda, MD 20892, USA.

International Journal of Biological Sciences
|March 2, 2016
PubMed
Summary
This summary is machine-generated.

Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer. Recent research into tumor biology reveals new vulnerabilities and potential early detection biomarkers to improve patient outcomes.

Keywords:
Pancreatic Cancer

More Related Videos

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.3K
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
09:25

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

27.6K

Related Experiment Videos

Last Updated: Mar 24, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

1.6K
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

20.3K
Bioluminescent Orthotopic Model of Pancreatic Cancer Progression
09:25

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

27.6K

Area of Science:

  • Oncology
  • Cancer Biology

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer mortality.
  • Clinically advanced PDAC is refractory to treatment, and early detection is hampered by a lack of reliable biomarkers.

Discussion:

  • Understanding tumor cell biology has identified novel molecular dependencies and vulnerabilities in PDAC.
  • These findings offer potential targets for therapeutic intervention and early detection strategies.

Key Insights:

  • Recent advancements in understanding PDAC biology are uncovering critical tumor cell vulnerabilities.
  • These insights are crucial for developing more effective treatments and early diagnostic tools.

Outlook:

  • Continued research into PDAC biology holds promise for overcoming current treatment challenges.
  • The focus is on translating these discoveries into improved clinical outcomes for patients with this deadly malignancy.